Dynamics of parasite clearance in cutaneous leishmaniasis patients treated with miltefosine
about
Systematic review of biomarkers to monitor therapeutic response in leishmaniasisMiltefosine for visceral and cutaneous leishmaniasis: drug characteristics and evidence-based treatment recommendationsMiltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasisMonitoring the response of patients with cutaneous leishmaniasis to treatment with pentamidine isethionate by quantitative real-time PCR, and identification of Leishmania parasites not responding to therapy.An update on pharmacotherapy for leishmaniasisCutaneous Leishmaniasis: Current Treatment Practices in the USA for Returning TravelersCutaneous leishmaniasis: recent developments in diagnosis and managementQuantification of Leishmania (Viannia) Kinetoplast DNA in Ulcers of Cutaneous Leishmaniasis Reveals Inter-site and Inter-sampling Variability in Parasite LoadOptimal dosing of miltefosine in children and adults with visceral leishmaniasis.Quantitative Kinetoplast DNA Assessment During Treatment of Mucosal Leishmaniasis as a Potential Biomarker of Outcome: A Pilot Study.Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis.Miltefosine for Mucosal and Complicated Cutaneous Old World Leishmaniasis: A Case Series and Review of the Literature.Duplex quantitative Reverse-Transcriptase PCR for simultaneous assessment of drug activity against Leishmania intracellular amastigotes and their host cellsImported cutaneous leishmaniasis caused by Leishmania major in a Chinese laborer who worked in Saudi Arabia.Interventions for Old World cutaneous leishmaniasis.
P2860
Q26866450-9EC97212-35CD-4ED1-BA36-B1FF08F5448EQ28088410-9AAAA4F6-1909-41ED-9864-D7277A0D258AQ28271849-3712DB36-0447-42B7-AEDC-E5C0E0B60B74Q29353558-2DD054B3-D3E3-495D-84A4-601F86CA04B2Q34945204-A4126B4D-5019-41A3-924C-DCE86F5EB091Q35180338-36911E59-5680-438D-B304-F9DC5E4B0C0BQ35187729-DC1E6435-1FCC-4508-B614-3AB3F674889DQ35708519-DB65F416-2E20-43B0-8FE1-F4E934F92C80Q36086339-B5F768E4-06F0-40B7-964A-D48BA40B69C5Q36455737-4525804A-C9CE-4C84-986F-A180635BD828Q38156421-97E4A1F9-4CCF-48A0-8B31-4F28B2CAD548Q38797460-2704471C-6C41-4E05-811C-573620FF3837Q39548200-C4D57416-353E-4080-8380-0BD49EE695D6Q42427702-67439D73-8EF8-487E-A248-B296D5260B09Q46250558-430646F1-C225-4D0D-B200-87D1F905E818
P2860
Dynamics of parasite clearance in cutaneous leishmaniasis patients treated with miltefosine
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Dynamics of parasite clearance ...... ients treated with miltefosine
@ast
Dynamics of parasite clearance ...... ients treated with miltefosine
@en
Dynamics of parasite clearance ...... ients treated with miltefosine
@nl
type
label
Dynamics of parasite clearance ...... ients treated with miltefosine
@ast
Dynamics of parasite clearance ...... ients treated with miltefosine
@en
Dynamics of parasite clearance ...... ients treated with miltefosine
@nl
prefLabel
Dynamics of parasite clearance ...... ients treated with miltefosine
@ast
Dynamics of parasite clearance ...... ients treated with miltefosine
@en
Dynamics of parasite clearance ...... ients treated with miltefosine
@nl
P2093
P2860
P3181
P1476
Dynamics of parasite clearance ...... ients treated with miltefosine
@en
P2093
Gerard J Schoone
Jos H Beijnen
Michèle van Vugt
Peter J de Vries
Pieter P A M van Thiel
Ymkje Stienstra
P2860
P3181
P356
10.1371/JOURNAL.PNTD.0001436
P407
P577
2011-12-13T00:00:00Z